USD 0.0
(0.0%)
Breakdown | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
---|---|---|---|---|---|---|
Operating Cash Flow | -797.7 Thousand | -5.79 Million | -490.37 Thousand | -145.90 | -11.48 Thousand | -17.2 Thousand |
Net Income | -5.93 Million | -19.69 Million | -635.32 Thousand | -52.27 Thousand | -45.95 Thousand | -43.29 Thousand |
Depreciation & Amortization | -933.1 Thousand | 1.55 Million | - | - | - | - |
Deferred income taxes | 1.52 Million | - | - | - | - | - |
Stock-based compensation | 342.57 Thousand | - | 38.24 Thousand | - | - | - |
Change in working capital | 2.3 Million | -1.01 Million | 183.36 Thousand | 35.83 Thousand | 21.48 Thousand | 17.06 Thousand |
Other non-cash items | 1.89 Million | 17.39 Million | -4363.05 | 16.29 Thousand | 12.97 Thousand | 9028.25 |
Investing Cash Flow | -80.81 Thousand | -165.43 Thousand | - | - | - | - |
Investments in PPE | -60.5 Thousand | -1.17 Million | - | - | - | - |
Acquisitions | - | 1.11 Million | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | -20.3 Thousand | -106.21 Thousand | - | - | - | - |
Financing Cash Flow | 856.93 Thousand | 2.36 Million | 1.66 Million | - | 7670.18 | 21.31 Thousand |
Debt repayment | -859.97 Thousand | -412.79 Thousand | -43.67 Thousand | - | -7670.18 | -21.31 Thousand |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | -219.04 Thousand | - | - | - | - | - |
Common Stock Issuance | 675.81 Thousand | 2.24 Million | 1.71 Million | - | - | - |
Other Financing Activities | 1.8 Million | 82.8 Thousand | - | - | - | - |
Accounts receivables | 132.62 Thousand | -1.99 Million | -34.05 Thousand | - | - | - |
Accounts payables | 2.26 Million | 1.21 Million | - | - | 21.37 Thousand | - |
Inventory | - | -149.23 Thousand | - | - | - | - |
Other working capital | -99.64 Thousand | -81.78 Thousand | 217.41 Thousand | 35.83 Thousand | 21.48 Thousand | 17.06 Thousand |
Cash at beginning of period | 141.67 Thousand | 1.17 Million | 592.57 | 694.92 | 4512.74 | 68.20 |
Cash at end of period | 92.05 Thousand | 141.67 Thousand | 1.17 Million | 592.57 | 694.92 | 4181.20 |
Capital Expenditure | -60.5 Thousand | -1.17 Million | - | - | - | - |
Effect of forex changes on cash | -29.02 Thousand | -1.03 | - | - | - | - |
Net cash flow / Change in cash | -49.62 Thousand | -1.03 Million | 1.17 Million | -102.34 | -3817.82 | 4113.00 |
Free Cash Flow | -858.21 Thousand | -6.97 Million | -490.37 Thousand | -145.90 | -11.48 Thousand | -17.2 Thousand |
Breakdown | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 FY | 2020 Q3 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -499.43 Thousand | -1.15 Million | -1.04 Million | -3.39 Million | -5.93 Million | -337.48 Thousand |
Depreciation & Amortization | 377.53 Thousand | 207.59 Thousand | 156.39 Thousand | 40.45 Thousand | -933.1 Thousand | 275.15 Thousand |
Deferred income taxes | - | - | - | - | 1.52 Million | - |
Stock-based compensation | -1199.00 | 300.92 Thousand | 31.31 Thousand | 170.87 Thousand | 342.57 Thousand | 50.33 Thousand |
Change in working capital | 34.62 Thousand | -1 Million | 1.49 Million | 1.52 Million | 2.3 Million | 278.65 Thousand |
Other non-cash items | 838.86 Thousand | 3.5 Million | -1.68 Million | 255.81 Thousand | 1.89 Million | 69.59 Thousand |
Investing Cash Flow | 130.15 | -11.31 Thousand | - | 231.43 Thousand | -80.81 Thousand | -104.96 Thousand |
Investments in PPE | 130.15 | -11.31 Thousand | - | 231.43 Thousand | -60.5 Thousand | -104.96 Thousand |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | -20.3 Thousand | -1.00 |
Financing Cash Flow | -224.7 Thousand | -109.8 Thousand | -37.74 Thousand | 229.36 Thousand | 856.93 Thousand | -143.03 Thousand |
Debt repayment | -221.83 Thousand | -110.64 Thousand | -108 Thousand | -148.08 Thousand | -859.97 Thousand | -143.03 Thousand |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | -17.76 Thousand | -219.04 Thousand | - |
Common Stock Issuance | 385.77 | -843.95 | 72.75 Thousand | 316.01 Thousand | 675.81 Thousand | - |
Other Financing Activities | - | - | - | 79.2 Thousand | 1.8 Million | - |
Accounts receivables | -133.53 Thousand | -119.73 Thousand | 2628.49 | -119.22 Thousand | 132.62 Thousand | 193.81 Thousand |
Accounts payables | 273.43 Thousand | -969.33 Thousand | 1.47 Million | - | 2.26 Million | - |
Inventory | - | - | - | - | - | - |
Other working capital | -105.27 Thousand | 82.42 Thousand | 14.74 Thousand | - | -99.64 Thousand | - |
Cash at beginning of period | 15.66 Thousand | 74.38 Thousand | 92.05 Thousand | 59.36 Thousand | 141.67 Thousand | 42.59 Thousand |
Cash at end of period | 15.67 Thousand | 15.66 Thousand | 74.38 Thousand | 92.05 Thousand | 92.05 Thousand | 59.36 Thousand |
Capital Expenditure | 130.15 | -11.31 Thousand | - | 231.43 Thousand | -60.5 Thousand | -104.96 Thousand |
Effect of forex changes on cash | 87.22 Thousand | 13.82 Thousand | -67.11 Thousand | -68.71 Thousand | -29.02 Thousand | -3050.00 |
Net cash flow / Change in cash | 10.00 | -58.72 Thousand | -17.66 Thousand | 32.69 Thousand | -49.62 Thousand | 16.76 Thousand |
Free Cash Flow | 136.54 Thousand | 36.93 Thousand | 88.34 Thousand | -127.95 Thousand | -858.21 Thousand | 162.85 Thousand |
SOBR
FDA
ESCORP
JACK
S24
EDRVF